Second Haplo-transplantation for Graft Failure
Not Applicable
Recruiting
- Conditions
- Graft FailureStem Cell Transplant Complications
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT06512519
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Modified Second Haplo-transplantation for Graft Failure
Not Applicable
Recruiting
- Conditions
- Stem Cell Transplant ComplicationsGraft Failure
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT06512545
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: A Randomized Control Study
Phase 2
Not yet recruiting
- Conditions
- Primary Antiphospholipid Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT06504420
The Effects of Programmed Death-ligand 1 on Postoperative Pain for Lung Cancer Patients
Not yet recruiting
- Conditions
- Lung CancerPostoperative Pain
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06503432
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Neoadjuvant Long-course Chemoradiotherapy Followed by Immunotherapy for Locally Advanced Mid-low Rectal Cancer
Phase 2
Recruiting
- Conditions
- Locally Advanced Rectal Cancer
- Interventions
- First Posted Date
- 2024-07-09
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06493240
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
The Real World Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China
Not yet recruiting
- Conditions
- CLL
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 490
- Registration Number
- NCT06489184
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Antibiotic Exposure During Pregnancy Affects Infant Gut Microbiota
Recruiting
- Conditions
- Antibiotics Affecting Newborn Gut Microbiota
- First Posted Date
- 2024-06-28
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 450
- Registration Number
- NCT06479941
- Locations
- 🇨🇳
The Peking University People's Hospital, Beijing, China
Interactions Between Environmental Exposures and Gut Microbiota in Early Life
Recruiting
- Conditions
- Infant Development
- First Posted Date
- 2024-06-28
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 756
- Registration Number
- NCT06479928
- Locations
- 🇨🇳
The Peking University People's Hospital, Beijing, China
Fecal Microbiota Transplantation in the Treatment of Major LARS
Not Applicable
Not yet recruiting
- Conditions
- Low Anterior Resection SyndromeFecal Microbiota Transplantation
- First Posted Date
- 2024-06-26
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06475430
Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
Not Applicable
Not yet recruiting
- Conditions
- Carcinoma, EndometrioidFertility Preservation
- Interventions
- Drug: Treatment Option 1 is a single-drug regimen, with oral medroxyprogesterone acetate (MPA) 500mg/d or MA 320mg/d.
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT06468215